Section 12-280-501 - Written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections(1) If a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 has a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is established in accordance with 42 CFR 483.75, the quality assessment and assurance committee may establish a facility list with written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections from the list.(2) If a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 does not have a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is established in accordance with 42 CFR 483.75, the facility may form a committee to establish a facility list with written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections from the list.Renumbered from C.R.S. § 12-42.5-501 and amended by 2019 Ch. 136, § 1, eff. 10/1/2019.Added by 2015 Ch. 289, § 2, eff. 6/5/2015.This section is similar to former § 12-42.5-501 as it existed prior to 2019.